CELESTICA INC
CELESTICA INC (CLS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-1.1 2 tm2621135d2_ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 EXECUTION VERSION Celestica Inc. Common Shares Underwriting Agreement August 5, 2026 Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 BofA Securities, Inc. One Bryant Park New York, New York 10036 T
Toronto’s TSX rose 1.6% to 35,801.59 as investors reacted to hopes for another opening of the Strait of Hormuz. Canadian dollar slipped to 71.10 U.S. cents. 5N Plus fell after Q2 results; Telus was downgraded after its results. Suncor and Orla moved on upcoming earnings. In the U.S., S&P 500 and Dow hit records; Palantir surged on Q2, with commercial revenue up 149% to $764 million.
Celestica Inc. (NYSE: CLS, TSX: CLS) said it completed its equity offering of 9,677,419 common shares at $310 per share. Including the underwriters’ option, 11,129,031 shares were sold for about $3.45 billion in gross proceeds. Net proceeds will be used for working capital, capital expenditures, and general corporate purposes.
Over the past 7 days, alphai's AI scored 19 news stories mentioning CLS (CELESTICA INC). Coverage has skewed bullish: 6 bullish, 9 neutral, and 4 bearish.
Recent CLS coverage spans corporate actions, insider activity and market movers.
In the last 30 days, CLS insiders filed 73 SEC Form 4 transactions — no purchases and 73 sales ($64.9M). The most active reporter was MIONIS ROBERT, Chief Executive Officer, with 49 filings. 100% of activity was filed under pre-arranged Rule 10b5-1 plans.
The 8-K discloses a new equity issuance via an underwriting agreement, which can pressure near-term price via dilution risk and float expansion.
The magnitude suggests a catalyst, but the article does not specify whether it was earnings, guidance, or a separate event.
The completed large equity raise is a near-term dilution and balance-sheet funding catalyst, likely shifting focus to use of proceeds and near-term EPS dilution.
The $3B equity raise is likely to pressure near-term dilution expectations but supports balance-sheet capacity for capex and working capital tied to AI/cloud demand.
This is an insider selling disclosure, not a fundamental update, but it can still affect near-term sentiment and positioning.
alphai scores every news story that mentions CLS with an AI model for sentiment and relevance, and aggregates insider trades from CELESTICA INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
CELESTICA INC (CLS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-1.1 2 tm2621135d2_ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 EXECUTION VERSION Celestica Inc. Common Shares Underwriting Agreement August 5, 2026 Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 BofA Securities, Inc. One Bryant Park New York, New York 10036 T
3 min readToronto’s TSX rose 1.6% to 35,801.59 as investors reacted to hopes for another opening of the Strait of Hormuz. Canadian dollar slipped to 71.10 U.S. cents. 5N Plus fell after Q2 results; Telus was downgraded after its results. Suncor and Orla moved on upcoming earnings. In the U.S., S&P 500 and Dow hit records; Palantir surged on Q2, with commercial revenue up 149% to $764 million.
4 min readCelestica Inc. (NYSE: CLS, TSX: CLS) said it completed its equity offering of 9,677,419 common shares at $310 per share. Including the underwriters’ option, 11,129,031 shares were sold for about $3.45 billion in gross proceeds. Net proceeds will be used for working capital, capital expenditures, and general corporate purposes.
2 min readCelestica priced a public equity offering of 9,677,419 common shares at C$310 per share, targeting about $3 billion in gross proceeds before fees. Underwriters received a 30-day option for up to 1,451,612 additional shares. Net proceeds will support working capital, capex, and general corporate purposes, with closing around Aug. 7, 2026, subject to conditions.
3 min readMIONIS ROBERT (Chief Executive Officer) sold 51,061 indirectly-held shares of CELESTICA INC (CLS) at an average of $368.41 ($361.89–$378.50, $18.81M total) across 18 trades on 2026-08-05 under a Rule 10b5-1 trading plan.
2 min readMIONIS ROBERT (Chief Executive Officer) sold 98,453 indirectly-held shares of CELESTICA INC (CLS) at an average of $368.99 ($360.28–$374.16, $36.33M total) across 20 trades on 2026-08-04 under a Rule 10b5-1 trading plan.
2 min readChawla Mandeep (Chief Financial Officer) sold 16,117 shares of CELESTICA INC (CLS) at an average of $369.32 ($360.18–$374.16, $5.95M total) across 15 trades on 2026-08-04 under a Rule 10b5-1 trading plan.
2 min readCelestica (TSE:CLS) announced a $3 billion equity offering of common shares to fund expansion in high-performance AI compute and data center Ethernet networking. The raise is led by BofA Securities, Citigroup and TD Securities, with net proceeds for working capital, capex and general corporate purposes. Closing depends on customary conditions and listing approvals.
3 min readCelestica Inc. (CLS) shares fell nearly 12% after the company priced a $3.0 billion public equity offering. According to the company, it sold 9.68 million common shares at $310 each, raising expected gross proceeds of $3.0 billion, and gave underwriters a 30-day option for up to 1.45 million additional shares. CLS traded around $319.48, down about $43.28.
2 min readCelestica (CLS) shares fell 13.7% after the company priced a $3 billion common stock offering at $310 per share, down from the prior close of $362.76. Celestica plans to sell about 9.68 million treasury shares, with underwriters able to buy 1.45 million more. Management said the raise supports AI compute and networking demand.
2 min read
